Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 6 news outlets

Readers on

mendeley: 11 Mendeley

So far, Altmetric has seen 7 news stories from 6 outlets.

Probiodrug AG, DE0007921835

Ad Hoc News, 16 Oct 2018

Probiodrug veröffentlicht Daten der SAPHIR-Studie in einer Peer-Review-Publikation Probiodrug veröffentlicht Daten der SAPHIR-Stu…

Probiodrug veröffentlicht Daten der SAPHIR-Studie in einer Peer-Review-Publikation

Ariva, 16 Oct 2018

DGAP-News: Probiodrug AG / Schlagwort(e): Studie/Sonstiges 16.10.2018 / 07:12 Für den Inhalt der Mitteilung ist der Emittent …

DGAP-News: Probiodrug veröffentlicht Daten der SAPHIR-Studie in einer Peer-Review-Publikation (deutsch)

Wall Street Online Denmark, 16 Oct 2018

Probiodrug veröffentlicht Daten der SAPHIR-Studie in einer Peer-Review-Publikation ^ DGAP-News: Probiodrug AG / Schlagwort(e)…

News story from Finanz Nachrichten on Tuesday 16 October 2018

Finanz Nachrichten, 16 Oct 2018

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.